BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Loading contract…
On Demand Availability of Drugs for Palliative Care | UKGovscan
Loading contract…
AWARDEDProcurement notice · NHS SURREY HEARTLANDS INTEGRATED CARE BOARDRef ocds-h6vhtk-065b70
On Demand Availability of Drugs for Palliative Care
Save Track Track buyer
Total Awarded
£2,244
Supplier
Medwyn Pharmacy
Procurement
Award procedure without prior publication of a call for competition
The aim of the service is to provide immediate and consistent access to palliative care medication across NHS Surrey Heartlands (and wider, work has been done collaboratively across Surrey) with the ultimate aim of providing the best level of End-of-Life care and reducing inappropriate admissions in the last weeks of a patient's life.
To improve access for people to these specialist medicines when they are required by ensuring prompt access and continuity of supply.
To support users, carers and clinicians by providing them with up-to-date information and advice, and referral where appropriate.
Medwyn Centre, Reigate Road, Dorking, RH4 1SD, United Kingdom
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
Lots
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
Lots
1
Initial Term Value
£2,244
Bids Received
1
Bids per Lot
1
Limited competition: at least one lot received only a single bid.
Lot
Value
Bids Received
Awarded To
Status
Lot 1
£2,244
initial term
1
single bid — no competition
Medwyn Pharmacy
active
Data note: the source feed marks these lots as cancelled even though their awards are active — an inconsistency in the published notice. The award status is shown above.
Award criteria
Weightings from the notice.
The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard100%
/(price)
Key Dates
Published
24 February 2026
Tender Open
-
Tender Deadline
-
Award Date
-
Contract Signed
4 February 2026
Contract Start
-
Contract End
-
Notice Amendments
Changes the buyer published to this notice after it first appeared.
Amendment 1
Additional information (VI.3): - → This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using direct award process C.
The contract duration is 24-months, from 01/04/2026 - 31/03/2028. The lifetime value of the contract is £2,244.00.
Award decision-makers:
NHS Surrey Heartlands ICB Medicines Optimisation Board (MOB) - 21st January 2026
NHS Surrey Heartlands ICB Commissioning, Contracting and Commercial Committee (CCC) - virtual resolution 27th January 2026
NHS Surrey Heartlands ICB Executive Committee - 4th February 2026
Julia Powell, CEO, Community Pharmacy Surrey and Sussex, declared a conflict of interest and did not attend MOB. No other conflicts of interest were identified.
Procurement Details
Method
Limited — the buyer invited chosen suppliers
Method Details
Award procedure without prior publication of a call for competition
Route to market
Direct award
Main category
Services
Category
–
Delivery location
UKJ2
Buyer Reference
ocds-h6vhtk-065b70
Legal Basis
Public Contracts Regulations 2015 (EU Directive 2014/24)